Skip to main content
Premium Trial:

Request an Annual Quote

Michael Rosenwald, John F. Lauerman, Scott Nibauer, Peter Lien

Premium

Michael Rosenwald, “Newsroom to Bio Boom,” p. 40, is a staff writer at the Boston Globe, where he writes about issues dealing with the new economy, the workplace, and recruiting talented workers. He also writes for the Globe Sunday magazine. Rosenwald has also worked as a crime reporter at the Post-Gazette, and written for the New York Times, ESPN Magazine, and other publications. He says his interest in science is a recent development and that he likes to think that his stories, such as the one about Tom Petzinger’s bioinformatics incubator, will make his parents feel guilty about punishing him when he brought home all those Cs and Ds in science.

 

Freelance science and medical writer John F. Lauerman, “Chip-Making, Harvard-Style,” p. 20, is a contributing editor and health columnist for Harvard Magazine, editorial board member of the public health journal Health and Human Rights, and associate editor at Lupus World. He is a frequent contributor to local and national newspapers, newsletters, magazines, and websites on the subjects of health and science. He is coauthor of two books, “Living to 100: Lessons in Living to Your Maximum Potential at Any Age” (Basic Books, 1999) and “Diabetes: Understand Your Condition, Make the Right Treatment Choices, and Cope Effectively” (Times Books, 1997). He lives with his wife and two children in Brookline, Mass.

 

Cover story photographers Scott Nibauer and Peter Lien met in the photography program at Rochester Institute of Technology, and formed a studio in Philadelphia in 1986. Since then they have been on the forefront on digital photography. Both photographers’ work has been published in Time, Red Herring, Philadelphia Magazine, Slam, Good Housekeeping, and Wine & Spirits, among others. In addition, Scott has shot the President’s Report for Fox Chase for many years.

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.